Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Director/PDMR Shareholding

1 Oct 2021 14:15

RNS Number : 7847N
Synectics PLC
01 October 2021
 

 

 

RNS

 

1 October 2021

 

 

 

Synectics plc

("Synectics" or the "Company")

 

Director/PDMR dealings

 

Synectics plc (AIM: SNX), a leader in the design, integration and support of advanced security and surveillance systems, has been notified that earlier today, the Trustee of the Company's HMRC Approved Employee Share Acquisition Plan ("ESAP") purchased a total of 14,843 ordinary shares of 20 pence each in the Company at a price of £1.05 per share in accordance with the ESAP's rules and on behalf of all ESAP participants, in respect of the six-month accumulation period ended on 30 September 2021.

 

Under the terms of the ESAP, participating members, including employees and certain Directors of the Company, contribute a fixed amount to the Trustee on a monthly basis. The Trustee acquires a number of shares at the end of the six-month accumulation period (the "Period") based upon the contributions made in the Period and determined by the lowest share price at either the beginning of the Period or on the date of purchase. In this instance, the share price used for the allocation of the number of shares for ESAP purposes was the price per share at the beginning of the Period which was £1.35.

 

As a result of this purchase, the Company has been notified that the following Executive Directors and PDMRs have acquired the following interests in shares of the Company:

 

Name

Position

Status

Number of Shares purchased by the Trustee

Paul Webb

Chief Executive

Executive Director

857

David Bedford

Finance Director

Executive Director

857

Greg Alcorn

Divisional Director

PDMR

857

David Lowe

Divisional Director

PDMR

857

 

In addition, David Bedford, Finance Director of the Company has notified the Company that he too purchased 5,000 ordinary shares of 20p each in the Company at £1.05 per share earlier today.

 

Following these purchases, the interests of Messrs Webb, Bedford, Alcorn and Lowe in the shares of the Company are as follows:

 

Name

Shares Held

Interest in Shares in Share Schemes

Resultant Total Interest

% of Issued Share Capital

Paul Webb

57,115

536,327

593,442

3.33%

David Bedford

20,000

186,857

206,857

1.16%

Greg Alcorn

-

25,655

25,655

0.14%

David Lowe

15,000

43,177

58,177

0.33%

 

 

 

For further information, please contact:

Synectics plc

Tel: +44 (0) 114 280 2828

Claire Stewart, Company Secretary

email: legalandsecretarial@synecticsplc.com

www.synecticsplc.com

Shore Capital

Tel: +44 (0) 20 7408 4050

Tom Griffiths / David Coaten / Henry Willcocks

 

 

 Ends

 

About Synectics plc

 

Synectics (AIM: SNX) is a leader in the design, integration and support of advanced security and surveillance systems that enable clients around the world to protect their people, communities, and assets.

 

Founded over 30 years ago, Synectics has deep industry experience across gaming, energy, urban transport, public space and critical infrastructure projects. The Group's expert engineering teams work in partnership with customers to create integrated product and technology solutions, proven in the most complex and demanding operating environments.

 

Find out more at www.synecticsplc.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEADEFEFLFFFA
Date   Source Headline
2nd Oct 20194:12 pmRNSDirector/PDMR Shareholding
23rd Jul 20198:31 amRNSContract Win
23rd Jul 20197:00 amRNSHalf-year Report
21st Jun 20198:16 amRNSNotification of Interim Results
17th Jun 20199:53 amRNSHolding(s) in Company
13th Jun 20198:36 amRNSChange of Adviser
4th Jun 20191:41 pmRNSHolding(s) in Company
23rd May 201912:45 pmRNSDirector/PDMR Shareholding
25th Apr 20197:40 amRNSAGM Statement
24th Apr 20191:00 pmRNSDirector/PDMR Shareholding
27th Mar 20198:32 amRNSExercise of Options and Director/PDMR dealings
26th Mar 20197:00 amRNSContract Win in Gaming Sector
25th Mar 201910:01 amRNSDirectorate Change
21st Mar 201912:09 pmRNSAnnual Report and AGM
21st Mar 20197:00 amRNSOil & Gas Contract Win
8th Mar 20193:59 pmRNSDirector/PDMR Shareholding
26th Feb 20197:00 amRNSFinal Results
25th Feb 20193:17 pmRNSHolding(s) in Company
19th Feb 20193:48 pmRNSDirectorate Update
29th Jan 20197:00 amRNSNotification of Final Results
29th Nov 20187:00 amRNSTrading Update
27th Nov 201811:29 amRNSDirector/PDMR Shareholding
29th Oct 201810:04 amRNSDirector/PDMR Shareholding
5th Oct 20187:00 amRNSDirector/PDMR Shareholding
25th Sep 20187:00 amRNSDirectorate Change
28th Aug 20187:00 amRNSSynectics secures UK custodial sites
14th Aug 20184:00 pmRNSDirector/PDMR Shareholding
17th Jul 20187:00 amRNSInterim Results
27th Jun 20187:00 amRNSNotification of Interim Results
1st Jun 20187:00 amRNSDirectorate Change
30th May 20183:23 pmRNSHolding(s) in Company
23rd May 20187:00 amRNSContract Win
11th May 20183:38 pmRNSDirector/PDMR Shareholding
27th Apr 201811:42 amRNSDirector/PDMR Shareholding
26th Apr 20181:12 pmRNSResult of AGM
26th Apr 20187:00 amRNSAGM Statement
29th Mar 20182:09 pmRNSDirector/PDMR Shareholding
27th Mar 20184:52 pmRNSHolding(s) in Company
26th Mar 20187:00 amRNSContract Win
21st Mar 20187:01 amRNSAnnual Report and Notice of AGM
21st Mar 20187:00 amRNSDirectorate Change
20th Feb 20187:00 amRNSFinal Results
23rd Jan 20187:00 amRNSNotification of Final Results
8th Jan 20183:19 pmRNSElectronic Communication with Shareholders
4th Jan 20181:15 pmRNSHolding(s) in Company
13th Dec 20171:43 pmRNSHolding(s) in Company
12th Dec 20177:00 amRNSTrading Update
1st Dec 20175:35 pmRNSAIM Disclosure Update
30th Oct 20174:40 pmRNSDirector/PDMR Shareholding
16th Oct 20173:23 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.